Holen Sie sich die Stockscreener-App
1.68
3.70%
0.06
Finanzdaten der Chemomab Therapeutics Ltd Adr-Aktie (CMMB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
4.71%
9.049
|
8.642 | 8.317 | 6.254 | 5.32 |
| Income/Loss From Continuing Operations Before Tax |
5.69%
-8.732
|
-8.262 | -8.08 | -6.734 | -5.104 |
| Income Tax Expense/Benefit |
110.00%
0.021
|
0.01 | - | -0.544 | - |
| Income/Loss From Continuing Operations After Tax |
5.81%
-8.753
|
-8.272 | -8.08 | -6.19 | -5.104 |
|
Net Income/Loss
|
5.81%
-8.753
|
-8.272 | -8.08 | -6.19 | -5.104 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
29,185%
221.00
|
-0.7598 | 228.77 | 228.17 | -0.041 |
| Diluted Average Shares |
29,185%
221.00
|
-0.7598 | 228.77 | 228.17 | -0.041 |
| Basic Earnings Per Share |
11.11%
0.04
|
0.036 | 0.035 | 0.027 | 0.023 |
| Diluted Earnings Per Share |
11.11%
0.04
|
0.036 | 0.035 | 0.027 | 0.023 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):